Ocuphire Pharma
submission targeted in late | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
58 of 114
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Results
March 2022
submission targeted in late with expected | Ocuphire Pharma
Related slides by other companies
Navidea Biopharmaceuticals
Investor Presentation
May 2022
path to submission | Navidea Biopharmaceuticals
argenx SE
Investor Presentation
March 2023
strengthened data story to clear clinical benefit broadened safety immunology | argenx SE
Apollomics
SPAC
September 2022
pipeline of early clinical and preclinical programs | Apollomics
Mainz Biomed NV
Investor Presentation
June 2023
next generation clinical validation and trials late | Mainz Biomed NV
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights